Beta Bionics (BBNX) Free Cash Flow (2024 - 2026)

Beta Bionics has disclosed Free Cash Flow across 3 years of filings, most recently posting -$25.2 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$25.2 million, down 24.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$61.1 million (down 2.86% YoY), and the FY2025 annual result was -$56.2 million, down 8.81% from the prior year.
• Free Cash Flow came in at -$25.2 million for Q1 2026 at Beta Bionics, down from -$13.9 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$8.7 million in Q3 2025 to a low of -$25.2 million in Q1 2026.
• The 3-year median for Free Cash Flow is -$13.4 million (2025), against an average of -$14.8 million.
• Peak annual rise in Free Cash Flow reached 24.58% in 2025, while the deepest fall reached 61.82% in 2025.
• Beta Bionics' Free Cash Flow stood at -$14.8 million in 2024, then climbed by 6.43% to -$13.9 million in 2025, then slumped by 81.54% to -$25.2 million in 2026.
• The last three Free Cash Flow figures came in at -$25.2 million (Q1 2026), -$13.9 million (Q4 2025), and -$8.7 million (Q3 2025), per Business Quant data.